Patient Characteristics and Survival Outcomes of Non-Metastatic, Non-Clear Cell Renal Cell Carcinoma
BackgroundNon-clear cell renal cell carcinoma (ccRCC) includes histologically and molecularly distinct subtypes such as papillary, chromophobe, collecting duct, and sarcomatoid RCC, with an incidence ranging from 20% to 25%. Oncologic outcomes and the role of adjuvant systemic therapy [vascular endo...
Main Authors: | Josiah An, Vignesh T. Packiam, Adithya Chennamadhavuni, Jordan Richards, Jayanshu Jain, Sarah L. Mott, Rohan Garje |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.786307/full |
Similar Items
-
Association between PD-L1 Expression and the Prognosis and Clinicopathologic Features of Non-Clear Cell Renal Cell Carcinoma
by: Magdalena Chrabańska, et al.
Published: (2024-03-01) -
Sarcomatoid Transrormation of Chromophobe Renal Cell Carcinoma
by: Moeinadin Safavi, et al.
Published: (2016-01-01) -
Treatment outcomes of metastatic nonclear cell renal cell carcinoma: A single institution retrospective analysis
by: Vivek Agarwala, et al.
Published: (2018-01-01) -
The Metastasis Pattern of Renal Cell Carcinoma Is Influenced by Histologic Subtype, Grade, and Sarcomatoid Differentiation
by: Hyung Kyu Park
Published: (2023-10-01) -
Immune checkpoint inhibitors in non-conventional histologies of renal-cell carcinoma
by: Melissa Bersanelli, et al.
Published: (2023-01-01)